Investigator Initiated Studies support independent investigators and institutions conducting clinical and basic science research to advance knowledge of CSL products and the diseases they treat.
CSL Grants support organizations delivering independent education and advocacy in CSL Behring’s areas of interest to strengthen clinical understanding, empower patients and improve care.
Patient Organisation Grants support patient organisations’ independent education, awareness, and advocacy initiatives to strengthen patient voice and improve care across CSL Behring’s areas of interest and rare diseases.
Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.